Hemochromatosis--Genetic Prevalence and Penetrance
NCT00006312 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2016-01-15
Summary
To examine the cost effectiveness of hereditary hemochromatosis (HH) screening in primary care.
Conditions
- Blood Disease
- Hemochromatosis
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
University of Rochester
lead OTHER
Principal Investigators
-
Pradyumna Phatak · University of Rochester
Eligibility
- Max Age
- 100 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-07-31
- Completion
- 2003-05-31
More Related Trials
-
HEPFER-Evaluation of a New Phenotypic Biological Marker in Genetic Type 1 Hemochromatosis
NCT01784939 ·Status: COMPLETED
-
Bone Status on Patients With Genetic Hemochromatosis: a 3 Years Descriptive and Evolutionary Study
NCT01556360 ·Status: COMPLETED
-
Study of the Pathogenesis of Porphyria Cutanea Tarda
NCT00005103 ·Status: COMPLETED
-
Evaluation of Low-cost Techniques for Detecting Sickle Cell Disease and β-thalassemia in Nepal and Canada
NCT05506358 ·Status: COMPLETED ·Phase: NA
-
Immunological Effects of Iron Supplementation in HHT Disease
NCT07111598 ·Status: RECRUITING ·Phase: NA
-
Ferritin as a Predictor for Anemia in Pregnancy
NCT03565198 ·Status: UNKNOWN
-
Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Hereditary Hemochromatosis (HH) Patients
NCT01398644 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis
NCT00440986 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Inhibiting Dietary Iron Absorption in Subjects With Hereditary Hemochromatosis by a Natural Polyphenol Supplement
NCT03990181 ·Status: COMPLETED ·Phase: NA
-
Quality and Biologic Characteristics of Red Blood Concentrates Obtained From Individuals With Elevated Ferritin.
NCT05742035 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis
NCT00000595 ·Status: COMPLETED ·Phase: PHASE2
-
Iron Replacement in Blood Donors
NCT00327067 ·Status: COMPLETED
-
Transferrin Saturation Coefficient and Ferritinemia in Diagnosis of Iron Deficiency
NCT04139265 ·Status: COMPLETED
-
PTG-300 in Subjects With Hereditary Hemochromatosis
NCT04202965 ·Status: COMPLETED ·Phase: PHASE2
-
Relative Contributions of Red Cell Catabolism and Dietary Absorption to Fetal Iron Accretion During Pregnancy
NCT01588665 ·Status: COMPLETED
-
Erythrocyte Apheresis Versus Phlebotomy in Hemochromatosis
NCT00509652 ·Status: UNKNOWN ·Phase: NA
-
Iron Profile in Patients With Congenital Cyanotic Heart Disease
NCT04104061 ·Status: UNKNOWN
-
Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy
NCT00202436 ·Status: COMPLETED ·Phase: PHASE3
-
Interest of Reticulocyte Haemoglobin Content (RET-he) in Management of Functional Anemia for Patient With Solid Tumor
NCT03656172 ·Status: COMPLETED
-
Absorption of Heme and Non-Heme Iron in Pregnant and Non-pregnant Women and Mechanisms of Fetal Iron Transfer
NCT01019096 ·Status: COMPLETED
-
Genetics and Pain Severity in Sickle Cell Disease
NCT01441141 ·Status: COMPLETED
-
Detection of β Thalassemia Carriers by Red Cell Parameters Obtained From the H2 Automatic Counter
NCT00481221 ·Status: UNKNOWN
-
Rare Iron Overloads Except C282Y Homozygosity : Description and Characterization.
NCT01541813 ·Status: TERMINATED
-
Iron Homoeostasis in Inflammation
NCT02155114 ·Status: COMPLETED
-
Studies in Porphyria I: Characterization of Enzyme Defects
NCT00004331 ·Status: UNKNOWN